The report "Chromatography Columns Market By Column Type (Ion Exchange, Size Exclusion, Reverse and Normal Phases, HPLC, Affinity, Chiral), Capacity (1-100 ml, 100-1000 ml, >1 liter), End User (Pharma & Biotech, CRO, CDMO) Forecast to 2031" is projected to reach USD 4.22 billion by 2031 at a CAGR of 7.3%.

 Browse 200 market data Tables and 80 Figures spread through 250 Pages and in-depth TOC on "Chromatography columns by Column Type (Ion Exchange, Size Exclusion, Reverse and Normal Phases, HPLC, Affinity, Chiral), Capacity (1-100 ml, 100-1000 ml, >1 liter), End User (Pharma & Biotech, CRO, CDMO) Global Forecast to 2031"

Download PDF- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143527928

The demand for chromatography columns is growing due to the analysis of complex samples, including proteins, biomolecules, biologics, and small molecules. Laboratories frequently replace older columns or upgrade to next-generation formats to maintain accuracy and efficiency, creating recurring demand for chromatography columns. Leading manufacturers are introducing columns with improved stationary phases and compatibility with automated and high-throughput systems, enabling laboratories to streamline workflows and achieve reliable performance across diverse applications.

More than 1000 ml segment dominated the market in 2025.

More than 1000 ml accounts for the dominant share of the chromatography columns market by capacity, due to large-volume columns are essential for modern biopharmaceutical and industrial-scale purification workflows. As manufacturers continue expanding production of biologics, including antibodies, recombinant proteins, and vaccines, there is a growing requirement for columns capable of handling higher sample loads and supporting continuous, high-throughput processing. Large-capacity columns enable improved operational efficiency by reducing overall purification cycles, minimizing downtime, and delivering more consistent batch performance.

The US is expected to hold the largest share of the global market during the forecast period.

The US is expected to hold the largest share of the chromatograph columns market as it hosts a highly developed ecosystem of pharmaceutical, biotechnology, and academic research institutions that rely heavily on chromatography for drug discovery, biologics development, quality control, and analytical testing. The strong presence of large biopharma firms, contract manufacturing organizations, and research laboratories ensures continuous demand for both analytical and preparative chromatography columns. Rigorously enforced regulatory standards for safety, purity, and compliance further drive widespread adoption of high-performance, reproducible chromatography solutions. Moreover, US-based instrument and consumables manufacturers and suppliers producing a wide variety of columns, high-grade stationary phases, and ready-to-use prepacked formats contribute to ease of access, innovation, and rapid uptake.

The major players in the Chromatography Columns Market include Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), Merck (US), and Bio-Rad Laboratories (US).

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.